| Literature DB >> 29587655 |
Alessandro D'Ambrosio1, Antonella Cotoia2, Renata Beck1, Potito Salatto1, Lada Zibar3,4, Gilda Cinnella1.
Abstract
BACKGROUND: Impedance Cardiography (ICG) is a non-invasive tool for continuous hemodynamic monitoring. Aims of our study were to assess the utility of ICG to evaluate the hemodynamic impact of 6 mg (GL6) vs 8 mg (GL8) levobupivacaine combined with fentanyl in healthy patients undergoing elective cesarean section; secondary, to compare the duration and quality of analgesia and anesthesia.Entities:
Keywords: Cesarean section; Hemodynamics; Hypotension; Impedance Cardiography; Levobupivacaine
Mesh:
Substances:
Year: 2018 PMID: 29587655 PMCID: PMC5870261 DOI: 10.1186/s12871-018-0498-4
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Fig. 1Flow chart of patients’ enrolment
Demographic and baseline hemodynamic data
| 6 mg Levobupivacaine | 8 mg Levobupivacaine | ||
|---|---|---|---|
| Age (years) | 34 ± 5 | 32 ± 5 | .235 |
| Height (cm) | 163 ± 6 | 164 ± 5 | .985 |
| Weight (kg) | 78 ± 12 | 83 ± 14 | .978 |
| BMI (kg/m2) | 29.5 ± 3 | 30 ± 4 | .696 |
| Gestational age (weeks) | 38 ± 1 | 38 ± 1 | .993 |
| Cephalic/ breech presentation (n) | 28/4 | 27/3 | .756 |
| MAP (mmHg) | 93 ± 8 | 96 ± 13 | .248 |
| HR (bmp) | 96 ± 15 | 100 ± 13 | .129 |
| CI (L/min/m2) | 3.5 ± .6 | 3.7 ± .6 | .310 |
| SVRI (dyn-sec/cm5/m2) | 1812 ± 336 | 1789 ± 363 | .704 |
| SVI (mL/beat/m2) | 41.2 ± 5 | 41 ± 6 | .715 |
| Duration of surgery (min) | 55 ± 15 | 55 ± 11 | .973 |
BMI = Body mass index, MAP = mean arterial pressure, HR = heart rate, bmp = beats per minute, CI = cardiac index, SVRI = systemic vascular resistance index, SVI = stroke volume index
Data are expressed as mean ± standard deviation or number
Baseline values are defined as average of the first 5 min of measurements before neuraxial anesthesia
Fig. 2Mean arterial pressure (mmHg) and systemic vascular resistance index (dyn-sec/cm5/m2) trend. Data are presented as mean in fifteen patients in GL6 group and fifteen patients in GL8 group. * § P < .001; ^ P = .035
Fig. 3Cardiac index (L/min/m2), heart rate (bpm) and SVI (mL/beat/m2) trends. Data are presented as mean in fifteen patients in L6 group and fifteen patients in L8 group. ° P = .003; + P = .052
Intraoperative data
| 6 mg Levobupivacaine | 8 mg Levobupivacaine | ||
|---|---|---|---|
| Patients with hypotension (n,%) | 15 (47%) | 15 (50%) | .012 |
| Ephedrine (mg) | 3.4 ± 3.3 | 5.7 ± 3.5 | .010 |
| Fluids (ml/kg) | 19 ± 6 | 17 ± 5 | .075 |
| Shivering n (%) | 5 (16%) | 3 (10%) | .948 |
| Pruritus n (%) | 2 (6%) | 1 (3%) | .951 |
| Nausea/vomiting n (%) | 7 (22%) | 9 (30%) | .917 |
| Time to birth (min) | 8.8 ± 2 | 9.1 ± 2 | .429 |
| Intravenous rescue dose (n, %) | 5 (15.6%) | 3 (10%) | .357 |
| Patient satisfaction score | 2.5 ± .6 | 2.6 ± .6 | .618 |
| Surgeon satisfaction score | 2.8 ± .4 | 2.9 ± .3 | .628 |
Data are expressed as mean ± standard deviation or number of patients and percentage as appropriate
Patient and surgeon satisfaction was assessed using a descriptive 3-point verbal rating score (3 = extremely satisfied; 2 = satisfied; 1 = not satisfied)
Intravenous rescue dose = 50 μg fentanest + 1 mg midazolam
Sensory and motor block characteristics
| 6 mg Levobupivacaine (n = 32) | 8 mg Levobupivacaine (n = 30) | P value | |
|---|---|---|---|
| Maximal sensory block height (n) | |||
| T1 dermatome | 27 | 23 | .999 |
| T2 dermatome | 2 | 0 | .999 |
| C8 dermatome | 3 | 7 | .999 |
| Onset time of sensory block (min) | 3.2 ± 1.4 | 2.8 ± .9 | .841 |
| Offset time of sensory block (min) | 157.2 ± 42 | 163.6 ± 33 | .735 |
| Regression time of 2 dermatomes (min) | 62.4 ± 20 | 58 ± 14 | .547 |
| Motor block | |||
| Bromage score 0 (n,%) | 23 (71.9%) | 6 (18.7%) | .001 |
| Bromage score 1 (n, %) | 4 (12.5%) | 7 (23.3%) | |
| Bromage score 2 (n, %) | 5 (15.6%) | 14 (46.7%) | |
| Bromage score 3 (n, %) | 0 (0%) | 3 (10%) | |
| Onset time of motor block (min) | 1.2 ± .4 | 1.9 ± 1.6 | .228 |
| Offset time of motor block (min) | 60 ± 18 | 57 ± 7 | .556 |
Data are presented as mean ± standard deviation or number and percentage of patients
Neonatal demographics, Apgar scores and umbilical cord acid-base measurements
| 6 mg Levobupivacaine (n = 32) | 8 mg Levobupivacaine (n = 32) | P value | |
|---|---|---|---|
| Apgar scores | |||
| 1 min | 8 ± .9 | 8 ± 1 | .656 |
| 5 min | 9 ± .5 | 9 ± .8 | .849 |
| Umbilical vein | |||
| pH | 7.4 ± .1 | 7.4 ± 0 | .965 |
| PvO2 (mmHg) | 25 ± 9 | 27 ± 5 | .736 |
| PvCO2 (mmHg) | 42 ± 4 | 40 ± 5 | .446 |
| Base excess (mmol/L) | −1.8 ± 1 | −1.9 ± .6 | .941 |
| Umbilical artery | |||
| pH | 7.3 ± 0 | 7.3 ± 0 | .948 |
| PvO2 (mmHg) | 14 ± 5 | 11 ± 5 | .724 |
| PvCO2 (mmHg) | 54 ± 5 | 54 ± 6 | .952 |
| Base excess (mmol/L) | −2 ± .8 | −2.1 ± .8 | .955 |
| Birth weight (g) | 3336 ± 381 | 3306 ± 365 | .751 |
Data are presented as mean ± standard deviation